Vivanza Biosciences Ltd SHARE PRICE [LIVE]

  
NSE: VIVANZA
N/A
BSE: 530057
18.80
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Vivanza Biosciences Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

VIVANZA News

Frequently Asked Questions

What is the Share price of Vivanza Biosciences Ltd (VIVANZA)?

Vivanza Biosciences Ltd (VIVANZA) share price as of March 31, 2023, on BSE is Rs 18.80 (BSE).

Can I buy Vivanza Biosciences Ltd (VIVANZA) shares?

Yes, You can buy Vivanza Biosciences Ltd (VIVANZA) shares by opening a Demat account with Angel One.

How do I buy Vivanza Biosciences Ltd (VIVANZA) from Angel One?

Vivanza Biosciences Ltd (VIVANZA) share can be brought through the following modes:
  1. Direct investment: You can buy Vivanza Biosciences Ltd (VIVANZA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Vivanza Biosciences Ltd (VIVANZA) shares.

About VIVANZA

Today's live share price for Vivanza Biosciences Ltd is NSE: N/A, BSE: ₹ 18.80 with a current market capitalization of .

Engaged in the manufacture of large volume parenterals with an installed capacity of 18 lac pa at Sabalpur, Gujarat, Ivee Injectaa was incorporated in Mar.'82 as a private limited company. It was converted into a public limited company in May '92. The company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa. It also proposed to diversify into the manufacture of small volume parenterals with an installed capacity of 294 lac pa. It came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. Due to recessionary trends which lead to difficult business conditions in the year 1999-2000, the parenteral industry has suffered a setback. However, the company has been awarded rate contract for one year for the supply of company's products from the Government of Gujarat and collective efforts are being made to improve the working of the company.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers